Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
Volume 60 , Issue 20
Showing 1-31 articles out of 31 articles from the selected issue
ORIGINAL ARTICLES
  • Atsushi Hiraoka, Miho Onishi, Satsuki Koyama, Masaya Kato, Kaori Marui ...
    2021 Volume 60 Issue 20 Pages 3195-3203
    Published: October 15, 2021
    Released: October 15, 2021
    JOURNAL OPEN ACCESS
    Supplementary material

    Objective This study evaluated cases of pruritus, which is known to be associated with sleep disorder, in chronic liver disease (CLD) patients.

    Methods Questionnaires were given to 339 enrolled CLD outpatients in winter (November 2019 to March 2020) and again in summer (April to October 2020) (median interval: 104 days). Relative changes in symptoms shown by a visual analogue scale (VAS) and Kawashima's pruritus score between winter and summer were evaluated in Study 1 (n=199), while Study 2 examined the clinical features of patients with sleep disorder based on the results of the second questionnaire (n=235, median age 70 years old; 141 men, liver cirrhosis 37%).

    Results Study 1. There was a significant relationship in VAS between daytime and nighttime for each season, as well as between winter and summer for each time period (p<0.001). A comparison of Kawashima's pruritus scores for the daytime and nighttime showed no significant seasonal differences (p=0.436 and 0.828, respectively). When Kawashima's score increased, so did the average VAS for both daytime (0:1:2:3:4=0.4±0.2:1.4±0.9:3.0±1.8:5.9±2.1:6.2±2.3) and nighttime (0:1:2:3:4=0.3±0.1:1.4±1.5:3.5±2.3:6.7±2.6:6.9±1.8) (p<0.001 for both). Study 2. Twenty subjects (8.5%) complained of sleep disorder. An elevated FIB-4 index (≥3.07) showed a good predictive value for sleep disorder (p<0.01). The cut-off for the daytime and nighttime VAS values for existing sleep disorder were 1.6 [area under the curve (AUC) 0.901] and 3.4 (AUC 0.931). The respective sensitivity, specificity, and positive and negative predictive values for sleep disorder based on Kawashima's score (≥2) were 0.85, 0.28, 0.10, and 0.95 for the daytime and 1.00, 0.29, 0.12, and 1.00 for the nighttime.

    Conclusion Intervention against pruritus is recommended in CLD patients with a high Kawashima's score (≥2) in any season, especially with an elevated FIB-4 index.

    Download PDF (1252K)
  • Tatsuhiro Yamazaki, Takeshi Tomoda, Hironari Kato, Kazuya Miyamoto, Ak ...
    2021 Volume 60 Issue 20 Pages 3205-3211
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: May 07, 2021
    JOURNAL OPEN ACCESS

    Objective Strict follow-up is recommended for branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) to avoid missing the development of high-risk stigmata (HRS) at a premalignant stage. This study explored the risk factors associated with the development of HRS during follow-up.

    Methods We performed a retrospective analysis of 283 patients with BD-IPMN, treated at Okayama University Hospital in Japan between January 2009 and December 2016. Only patients with imaging studies indicative of classical features of BD-IPMN without HRS and followed for over one year were included in the study. We performed radiological follow-up every six months and collected patients' demographic data, cyst characteristics, and clinical outcomes and used univariate logistic regression models to determine the odds of developing HRS.

    Results Ten patients (3.5%) developed HRS after a median surveillance period of 55.8 months. The main pancreatic duct (MPD) size (5-9 mm) and cyst growth rate (>2.5 mm/year) were both suggested to be possible risk factors for the development of HRS [odds ratio, 14.2; 95% confidence interval (CI), 3.1-65.2, p=0.0006, and odds ratio, 6.1; 95% CI 1.5-25.5, p=0.014]. Regarding the number of worrisome features (WFs), the rate of HRS development was 2.0% (4/199) in cases with no WF, 1.6% (1/62) in cases with single WF and 22.7% (5/22) in cases with multiple WFs, respectively. The rate of HRS development was significantly higher in cases with multiple WFs than in the other cases (p<0.0001).

    Conclusion MPD dilation, rapid cyst growth, and multiple WFs were significant risk factors for the development of HRS. In the presence of such features, it is necessary to closely follow the development of HRS and avoid missing the best opportunity to perform surgical intervention.

    Download PDF (635K)
  • Masato Asaoka, Eri Hagiwara, Satoshi Etori, Katsuyuki Higa, Satoshi Ik ...
    2021 Volume 60 Issue 20 Pages 3213-3219
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: April 26, 2021
    JOURNAL OPEN ACCESS

    Objective Although multiple nontuberculous mycobacteria (NTM) species can be isolated from the same patient, little has been reported on co-isolation. We clarified the trends and characteristics of the co-isolation of multiple NTM species.

    Methods To collect data on multiple NTM isolation, we first extracted all patients who visited our hospital from 2006 through 2015 with a diagnosis of NTM lung diseases other than Mycobacterium avium complex (MAC) and then reviewed their medical records to evaluate the co-isolation of multiple NTM species.

    Results Of 213 patients with non-MAC lung disease, the most common NTM species was M. gordonae (32%), followed by M. kansasii (20%) and M. abscessus (14%). Non-MAC NTM lung disease tended to be associated with middle age with a low body mass index and male predominance. Multiple NTM species were isolated from 55 (26%) of the 213 patients. The clinical characteristics associated with multiple NTM species isolation included female predominance, never smokers and the absence of cavity lesions in the lungs. The highest co-isolation rate was observed in patients with M. gordonae isolation (30%), followed by M. furtuitum isolation (26%) and M. abscessus isolation (20%). Only MAC was isolated when co-isolated with M. abscessus. Among M. szulgai, M. peregrinum and M. terrae isolation, no other NTM species were detected.

    Conclusion Co-isolation of multiple NTM species was not uncommon, with 26% of patients with non-MAC NTM lung diseases showing co-isolation with multiple NTM species. Each NTM species had distinct characteristics in terms of co-isolation.

    Download PDF (907K)
  • Tomoyo Oguri, Shinji Sasada, Takashi Shimada, Kota Ishioka, Saeko Taka ...
    2021 Volume 60 Issue 20 Pages 3221-3224
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: April 26, 2021
    JOURNAL OPEN ACCESS

    Background Homeless persons are those who carry out their activities of daily living in city parks and other facilities. Little is known about homeless patients with lung cancer in Japan. Therefore, we characterized the clinical features and outcomes of homeless people in metropolitan Tokyo.

    Methods Between January 2014 and August 2018, 2,068 homeless patients were admitted to the homeless patient care unit at Tokyo Saiseikai Central Hospital. Of these, 13 patients were treated for primary lung cancer. We retrospectively analyzed the patients' clinical characteristics, including their age, gender, treatment, and outcome, obtained from the hospital's electronic medical records.

    Results A total of 13 patients were treated for lung cancer. The median age was 66.2 (range, 51-77) years old. Twelve patients (92.3%) were smokers. All of the patients were men and had advanced lung cancer. Of these, four patients had adenocarcinoma, four had squamous carcinoma, and four had other histologies. Ten patients received chemotherapy, and 3 received chemoradiotherapy (carboplatin, n=8; cisplatin, n=2, immune check point inhibitor, n=2; other, n=1). Of the patients on first-line treatment, 58% discontinued treatment, with 71% doing so willfully. The median overall survival was 7.5 (1-44) months. During the study, nine patients died in the hospital, and four were lost to follow up.

    Conclusion It is difficult for homeless patients to continue chemotherapy, and they often quit therapy willfully. Therefore, it is necessary to develop an education and health insurance support system to ensure treatment continuity in a good social environment.

    Download PDF (124K)
CASE REPORTS
  • Yasuyuki Tanaka, Yumi Tokubayashi, Mitsuya Kikuchi, Shigehiko Fujii, T ...
    2021 Volume 60 Issue 20 Pages 3225-3229
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: May 07, 2021
    JOURNAL OPEN ACCESS

    An 80-year-old woman was found to have a 40-mm depressed-type gastric cancer. Computed tomography showed multiple lymph node enlargement, including paraaortic lymph nodes. The extent of lymph node enlargement was significant compared with the depth of the primary lesion. We conducted distal gastrectomy, D2 lymph node dissection, and a paraaortic lymph node biopsy. Microscopically, the tumor was diagnosed as mucosal cancer. In the dissected lymph nodes, noncaseating granuloma was found without metastasis of adenocarcinoma. Immunohistochemical staining using Propionibacterium acnes-specific antibodies showed a large number of P. acnes-positive cells in the granulomas. Finally, the tumor was diagnosed as early-stage gastric cancer and sarcoidosis.

    Download PDF (1228K)
  • Ai Kawada, Shinichi Iwamura, Kenji Yorita, Rikiya Daike, Yu Tanaka, Na ...
    2021 Volume 60 Issue 20 Pages 3231-3237
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: April 12, 2021
    JOURNAL OPEN ACCESS

    The onset of autoimmune hepatitis (AIH) during pregnancy is rare and often poses a diagnostic challenge. A 29-year-old Japanese woman experienced epigastric pain and nausea during the third trimester of her third pregnancy. Three days after the symptom onset, an emergency Caesarean section was performed because of suspected acute fatty liver of pregnancy; however, the patient's liver dysfunction worsened afterward. Despite normal serum IgG concentration and absence of autoantibodies, biopsy-proven severe hepatitis with centrilobular zonal necrosis and good biochemical response to corticosteroids led to a diagnosis of AIH. Therefore, AIH should be included in the differential diagnosis of liver dysfunction during pregnancy.

    Download PDF (635K)
  • Masami Minemura, Kazuto Tajiri, Yuka Hayashi, Naoki Takahashi, Kasumi ...
    2021 Volume 60 Issue 20 Pages 3239-3243
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: April 26, 2021
    JOURNAL OPEN ACCESS

    Accurate genotyping is important to improve the treatment of hepatitis C virus (HCV) infection. We herein report a 44-year-old Japanese man with hemophilia A and coinfection of HCV and human immunodeficiency virus (HIV) who was diagnosed with HCV genotype 4 by direct sequencing. Two genotyping tests based on the nested polymerase chain reaction method that we used misdiagnosed his genotype as 2b and 1b. Although several HCV genotyping tests are available in Japan, it is important to recognize that some cannot detect genotype 4. Care should be taken when genotyping HCV patients who have received non-heated coagulation factor preparations or were infected abroad.

    Download PDF (952K)
  • Daisuke Miyahara, Yuichi Moriyama, Yuka Yamazaki, Hironobu Tanii, Yosh ...
    2021 Volume 60 Issue 20 Pages 3245-3249
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: March 29, 2021
    JOURNAL OPEN ACCESS

    Drug-induced lupus (DIL) is a drug-mediated immune reaction with the same symptoms as that of lupus erythematosus. We herein report the first case of tocilizumab-induced lupus syndrome presenting with cardiac tamponade. A 65-year-old man presented with cough, exertional dyspnea, and chest pain after 2 months of tocilizumab therapy for rheumatoid arthritis. Echocardiography revealed marked pericardial effusion. Antinuclear antibodies and anti-double-stranded deoxyribonucleic acid antibodies were positive. The diagnosis of cardiac tamponade due to tocilizumab-induced lupus syndrome was made. He had no recurrence of pericardial effusion after tocilizumab discontinuation. Clinicians should be alert for lupus syndrome in patients receiving tocilizumab.

    Download PDF (927K)
  • Shusuke Yagi, Tomoko Takahashi, Keiji Murakami, Momoyo Azuma, Mikio Su ...
    2021 Volume 60 Issue 20 Pages 3251-3255
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: April 19, 2021
    JOURNAL OPEN ACCESS

    Infective endocarditis (IE) may be acquired in the community as community-acquired (CA) IE or in the healthcare setting. In Japan, cases of CA-methicillin-resistant Staphylococcus aureus (MRSA) infection as skin infection have been increasing. CA-MRSA strains, including the USA300 clone, have higher pathogenicity and are more destructive to tissue than healthcare-associated MRSA strains because of the toxins they produce, including arginine-catabolic mobile element (ACME) and Panton-Valentine leukocidin (PVL). However, only a few IE cases induced by USA300 have been reported. We herein report a 64-year-old man who developed CA-IE from a furuncle caused by USA300 MRSA producing PVL and ACME, which resulted in complications of meningitis.

    Download PDF (2053K)
  • Kaito Koshino, Akihiro Endo, Nobuhide Watanabe, Koichi Okazaki, Kazuak ...
    2021 Volume 60 Issue 20 Pages 3257-3260
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: April 26, 2021
    JOURNAL OPEN ACCESS

    An 82-year-old woman was admitted to our hospital because of dyspnea and bradycardia during exertion. Electrocardiography revealed complete atrioventricular block. During pacemaker implantation, a small dose (12.5 mg) of hydroxyzine was injected for sedation, and torsade de pointes (Tdp) occurred. The QT interval was prolonged after administration of hydroxyzine, and Tdp was observed after the R on T phenomenon occurred, indicating that hydroxyzine was capable of prolonging the QT interval and causing Tdp. Therefore, we must be cautious when administering hydroxyzine for sedation during surgery, especially in patients with bradycardia.

    Download PDF (1130K)
  • Tatsuya Suwabe, Masahiko Oguro, Yoshifumi Ubara, Daisuke Ikuma, Hiroki ...
    2021 Volume 60 Issue 20 Pages 3261-3265
    Published: October 15, 2021
    Released: October 15, 2021
    JOURNAL OPEN ACCESS
    Supplementary material

    Renal cyst infection is a frequent and serious complication of autosomal dominant polycystic kidney disease (ADPKD) that is often difficult to treat and can be fatal. While nephrectomy is the standard therapy for severe refractory renal cyst infection, it can be associated with severe adverse events. We experienced a case of repetitive renal cyst infection in a 58-year-old Japanese man with ADPKD on dialysis. He underwent renal transcatheter arterial embolization (TAE) four months after the last episodes of renal cyst infection, and his renal cyst infection has not recurred since renal TAE. This case suggested that renal TAE is effective for preventing repetitive renal cyst infection.

    Download PDF (1086K)
  • Yasutaka Mochizuka, Masato Kono, Ryutaro Hirama, Yuiko Oshima, Kenichi ...
    2021 Volume 60 Issue 20 Pages 3267-3272
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: April 26, 2021
    JOURNAL OPEN ACCESS

    A 78-year-old man was admitted to our hospital with a fever and left chest pain. Computed tomography showed multiple lung nodules, narrowing of the right bronchus intermedius with mediastinal lymphadenopathy, and an osteolytic lesion. Bronchoscopic findings showed rapid progression of multiple polypoid lesions and the bronchial stenosis. A biopsy of the endobronchial lesions revealed non-necrotizing granulomatous inflammation, and a tissue culture identified Mycobacterium avium. An anti-human immunodeficiency virus antibody was negative. Finally, anti-interferon-gamma (IFN-γ) autoantibodies were detected, and the patient was diagnosed with disseminated nontuberculous mycobacterium infection with anti-IFN-γ autoantibodies. Antimycobacterial therapy was effective, and radiographic findings, including the endobronchial lesions, were resolved.

    Download PDF (987K)
  • Takashi Egawa, Keita Masuzawa, Sohei Nakayama, Ichiro Maeda, Satoshi T ...
    2021 Volume 60 Issue 20 Pages 3273-3277
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: April 12, 2021
    JOURNAL OPEN ACCESS

    Chemotherapy for multiple primary malignancies is challenging. We herein report a case of synchronous primary lung adenocarcinoma and hepatocellular carcinoma (HCC). A 72-year-old man was admitted for the evaluation of an abnormal shadow on his lung. Computed tomography revealed a lung nodule in the right upper lobe and multiple liver masses. He was diagnosed with synchronous primary lung adenocarcinoma and HCC. Atezolizumab, bevacizumab, carboplatin, and paclitaxel (ABCP) chemotherapy was efficacious for both tumors. ABCP chemotherapy may be a potential treatment option for synchronous primary lung adenocarcinoma and HCC.

    Download PDF (1709K)
  • Shuichiro Matsumoto, Manabu Suzuki, Sachi Matsubayashi, Akinari Tsukad ...
    2021 Volume 60 Issue 20 Pages 3279-3284
    Published: October 15, 2021
    Released: October 15, 2021
    JOURNAL OPEN ACCESS

    We herein report a 48-year-old man with a history of chronic atrial fibrillation (AF) and repeated hemoptysis after radiofrequency ablation. Contrast tomography showed soft tissue thickening of the left hilar region and left pulmonary vein stenosis. We performed bronchial artery embolization, but the hemoptysis did not disappear, and AF was not controlled. We performed left lung lobectomy and maze procedures since we considered surgical removal necessary as radical treatment. After the surgery, hemoptysis and atrial fibrillation did not recur. Refractory hemoptysis after catheter ablation is rare, but occasionally occurs in patients with severe pulmonary vein stenosis.

    Download PDF (2204K)
  • Yuki Yoshimatsu, Kazunori Tobino, Ryunosuke Ooi, Takuto Sueyasu, Saori ...
    2021 Volume 60 Issue 20 Pages 3285-3287
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: April 26, 2021
    JOURNAL OPEN ACCESS

    We experienced a patient who presented with lung abscess one month after aspirating barium during a gastric cancer screening examination. The patient had no subjective symptoms suggesting a swallowing disorder. Rigorous history taking under suspicion of aspiration and a further assessment of the cause of aspiration revealed hypopharyngeal cancer. Lung abscess and hypopharyngeal cancer, both treatable but potentially fatal conditions, were not diagnosed until one month after the aspiration. This highlights the need for guidance for patients and physicians to follow in the event of barium aspiration, as it is the most common complication of a barium examination. A health checkup for one condition (gastric cancer) may also be an opportunity to diagnose another underlying condition.

    Download PDF (306K)
  • Takashi Inao, Masashi Amano, Seishu Hashimoto, Chisato Izumi, Yodo Tam ...
    2021 Volume 60 Issue 20 Pages 3289-3293
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: May 07, 2021
    JOURNAL OPEN ACCESS

    Few reports have highlighted the serial changes in pulmonary hypertension during respiratory management. An 18-year-old girl with severe scoliosis was referred to our hospital for worsening dyspnea on exertion. Based on chest X-ray and transthoracic echocardiography findings showing a tricuspid regurgitation pressure gradient (TRPG) of 64 mmHg, the patient was diagnosed with severe alveolar hypoventilation due to thoracic deformity and severe pulmonary hypertension. Her oxygenation improved rapidly under noninvasive positive pressure ventilation, although partial pressure of carbon dioxide remained >80 Torr. Transthoracic echocardiography on day 7 showed clinically significant and rapid improvement of pulmonary hypertension with a TRPG of 30 mmHg.

    Download PDF (3674K)
  • Takehiro Tsuchiya, Atsushi Sano, Mai Kaneko, Satomi Mizutani, Tsutomu ...
    2021 Volume 60 Issue 20 Pages 3295-3297
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: April 26, 2021
    JOURNAL OPEN ACCESS

    Polycarbophil calcium (Polyful®; Mylan, Tokyo, Japan) is a stool stabilizer that absorbs liquid and swells to form a soft, bulky mass. A 75-year-old woman experienced sore throat and difficulty breathing immediately after taking the drug. Chest computed tomography showed a foreign body in the right intermediate bronchus. Bronchoscopy showed a white mass blocking the right intermediate bronchus. Since the mass was very fragile, we performed suctioning while breaking up the mass with a suction tube. The mass consisted of polycarbophil calcium. Since aspirated polycarbophil calcium swells and can obstruct bronchi, complete removal is crucial.

    Download PDF (484K)
  • Yuta Kaito, Shunsuke Yui, Kazuki Inai, Daishi Onai, Ryosuke Kinoshita, ...
    2021 Volume 60 Issue 20 Pages 3299-3304
    Published: October 15, 2021
    Released: October 15, 2021
    JOURNAL OPEN ACCESS

    Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ disorders, graft-versus-host disease (GVHD), and infectious diseases. Furthermore, there are many unclear points regarding central nervous system (CNS) complications, and the prognosis in patients with CNS complications is extremely poor. We herein report a 49-year-old woman who developed CNS-GVHD after a second transplantation for therapy-related myelodysplastic syndrome. CNS-GVHD in this case was refractory to all treatments, including steroids, and progressed. We also present a review of the literature about the symptoms, diagnosis, and treatment of CNS-GVHD.

    Download PDF (1003K)
  • Megumi Koshiishi, Toru Odate, Yukie Nakagawa, Jun Suzuki, Takuya Kumag ...
    2021 Volume 60 Issue 20 Pages 3305-3308
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: April 26, 2021
    JOURNAL OPEN ACCESS

    A 71-year-old woman with a four-year history of chronic lymphocytic leukemia (CLL) received ibrutinib as initial treatment due to progressive anemia and thrombocytopenia. Eleven months after the start of the treatments, although her cytopenia had ameliorated, she developed classic Hodgkin lymphoma, a rare form of Richter's transformation. She was successfully treated with two courses of adriamycin, vinblastin, bleomycin and dacarbazine followed by radiotherapy. In general, several clinical, genetic and molecular factors are associated with Richter's transformation. In addition, our present case suggested that ibrutinib could be a potential risk factor for Richter's transformation in CLL patients.

    Download PDF (579K)
  • Hiroko Iizuka, Sakiko Harada, Noriaki Iwao, Michiaki Koike, Masaaki No ...
    2021 Volume 60 Issue 20 Pages 3309-3315
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: May 07, 2021
    JOURNAL OPEN ACCESS

    Primary skeletal muscle lymphoma is extremely uncommon, and there have only been eight previous case reports on primary skeletal muscle peripheral T-cell lymphoma, not otherwise specified (PSM-PTCL, NOS). We herein report an autopsy case of a 71-year-old woman with PSM-PTCL, NOS, who had a 24-year history of systemic sclerosis treated with immunosuppressive drugs. A post-mortem examination revealed infiltration of lymphoma cells positive for T-cell markers, cytotoxic markers, and p53. This case was considered to be one of other iatrogenic immunodeficiency-associated lymphoproliferative disorder (OIIA-LPD). This is the first case categorized under both PSM-PTCL, NOS, and OIIA-LPD.

    Download PDF (1830K)
  • Tatsuya Ueno, Norihiro Hanabata, Atsuko Katagai, Rena Okudera, Akira A ...
    2021 Volume 60 Issue 20 Pages 3317-3320
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: April 19, 2021
    JOURNAL OPEN ACCESS

    Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel (LCIG) is an established device-aided therapy for advanced Parkinson's disease (PD). Phytobezoar associated with LCIG is a rare device-related complication and presents with exacerbations of gastrointestinal and PD symptoms. We herein report the case of a phytobezoar that was formed at a knot on the pigtail-shaped J-tube and developed only in association with postprandial abdominal pain, similar to a feeling of a tube being pulled in without an exacerbation of PD symptoms. Such abdominal pain may be a warning sign of phytobezoar in LCIG-treated patients. Despite device-related complications, high-pressure alarms are not always present, and PD symptoms are not always exacerbated.

    Download PDF (341K)
  • Ryuto Yoshida, Takuya Sasaki, Takashi Sunouchi, Masayuki Ueda, Mizuki ...
    2021 Volume 60 Issue 20 Pages 3321-3324
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: April 19, 2021
    JOURNAL OPEN ACCESS

    Steroid administration to patients with urea cycle disorders can cause hyperammonemia. We encountered a 36-year-old woman with neuromyelitis optica (NMO) complicated by ornithine transcarbamylase (OTC) deficiency. By reducing the doses of steroids and adequate infusion management, we were able to administer pulse steroid therapy without any severe complications. This case indicates the safety of steroid treatment in patients with urea cycle disorders.

    Download PDF (340K)
  • Taichi Nomura, Kosuke Iwami, Azusa Nagai, Kazufumi Tsuzaka, Ichiro Yab ...
    2021 Volume 60 Issue 20 Pages 3325-3328
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: May 07, 2021
    JOURNAL OPEN ACCESS

    Anti-mitochondrial antibody type 2 is a diagnostic marker of primary biliary cirrhosis and complicates myositis. Myositis with anti-mitochondrial antibody type 2 is clinically characterized by slowly progressive limb, cardiac, and respiratory muscle weakness as well as serum creatinine kinase elevations. However, there has been few cases with eye symptoms. We herein report a 59-year-old woman with anti-mitochondrial antibody type 2 who presented with diplopia and ptosis. Magnetic resonance imaging revealed bilateral ocular muscle enlargement and abnormally high intensities in the lower limb muscles. Corticosteroid therapy improved these symptoms. Myositis with anti-mitochondrial antibody type 2 can present with eye symptoms.

    Download PDF (1610K)
  • Shotaro Yamamoto, Takao Nagashima, Yoichiro Akiyama, Katsuya Nagatani, ...
    2021 Volume 60 Issue 20 Pages 3329-3333
    Published: October 15, 2021
    Released: October 15, 2021
    [Advance publication] Released: April 26, 2021
    JOURNAL OPEN ACCESS

    A 56-year-old woman presented with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody. No interstitial lung disease was detected. Despite treatment with methylprednisolone pulse therapy and cyclosporine, dysphagia developed. Furthermore, the presence of thrombocytopenia, elevated lactate dehydrogenase levels, and an undetectable haptoglobin level suggested the possibility of thrombotic microangiopathy (TMA). Disturbed consciousness developed shortly after TMA onset, and brain magnetic resonance imaging revealed hyperintensity lesions in the bilateral basal ganglia, thalami, and brainstem. The patient was diagnosed with atypical posterior leukoencephalopathy syndrome before dying of heart failure later that day. In conclusion, early TMA recognition and prompt intensive treatment are critical in such cases.

    Download PDF (444K)
PICTURES IN CLINICAL MEDICINE
feedback
Top